The Cooper Companies, Inc. (NASDAQ:COO) Position Boosted by Intech Investment Management LLC

Intech Investment Management LLC increased its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 301.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 39,697 shares of the medical device company’s stock after buying an additional 29,819 shares during the quarter. Intech Investment Management LLC’s holdings in Cooper Companies were worth $3,466,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Treasurer of the State of North Carolina grew its holdings in Cooper Companies by 0.9% in the 4th quarter. Treasurer of the State of North Carolina now owns 22,861 shares of the medical device company’s stock worth $8,652,000 after buying an additional 212 shares in the last quarter. Hsbc Holdings PLC grew its holdings in Cooper Companies by 55.3% in the 4th quarter. Hsbc Holdings PLC now owns 87,718 shares of the medical device company’s stock worth $33,188,000 after buying an additional 31,234 shares in the last quarter. Quantbot Technologies LP bought a new position in Cooper Companies in the 1st quarter worth approximately $2,211,000. Whittier Trust Co. grew its holdings in Cooper Companies by 298.9% in the 1st quarter. Whittier Trust Co. now owns 11,940 shares of the medical device company’s stock worth $1,211,000 after buying an additional 8,947 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its holdings in Cooper Companies by 43.1% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock worth $3,076,000 after buying an additional 10,616 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

COO has been the subject of a number of research reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Piper Sandler increased their price target on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Jefferies Financial Group raised Cooper Companies from a “hold” rating to a “buy” rating and increased their price target for the company from $107.00 to $115.00 in a research note on Tuesday, July 16th. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 price target (up from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Finally, Robert W. Baird increased their price target on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research note on Thursday, August 29th. Four research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $115.00.

Insider Activity

In other news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the sale, the chief executive officer now owns 165,273 shares in the company, valued at $18,267,624.69. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the sale, the chief executive officer now owns 165,273 shares of the company’s stock, valued at $18,267,624.69. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Brian G. Andrews sold 24,788 shares of Cooper Companies stock in a transaction on Thursday, September 5th. The shares were sold at an average price of $105.90, for a total value of $2,625,049.20. Following the sale, the chief financial officer now directly owns 6,614 shares of the company’s stock, valued at approximately $700,422.60. The disclosure for this sale can be found here. Insiders sold 256,373 shares of company stock worth $27,637,427 over the last quarter. Corporate insiders own 2.00% of the company’s stock.

Cooper Companies Price Performance

Shares of NASDAQ:COO opened at $110.49 on Monday. The Cooper Companies, Inc. has a one year low of $75.93 and a one year high of $112.38. The stock has a fifty day moving average of $97.93 and a 200-day moving average of $95.45. The company has a market capitalization of $22.00 billion, a PE ratio of 64.99, a price-to-earnings-growth ratio of 2.60 and a beta of 0.98. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99.

Cooper Companies (NASDAQ:COO) last released its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.05. The company had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.84 earnings per share. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 3.66 EPS for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.